Influence of inhaled procaterol on pulmonary rehabilitation in chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is a progressive condition that classically causes dyspnea during physical activity. Destruction of alveoli and bronchostenosis are thought to lead to shortness of breath and result in decreased physical activity. In this study, we examined the influence of inhaled procaterol on exercise therapy for pulmonary rehabilitation. Patients with moderate to severe stable COPD were randomly divided into 2 groups those who inhaled procaterol before exercise (n=10) and those who did not (control group) (n=11). For 12 weeks, all patients performed their pulmonary rehabilitation exercises at home. We measured the 6-minute walking distance (6MWD) to assess exercise tolerance and used St. George's respiratory questionnaire (SGRQ) to assess health-related quality of life (HRQOL) before and after the 12-week exercise program. Compared to the control group, the group receiving inhaled procaterol showed significant improvement of 6MWD and SGRQ scores. Our data suggest that a pulmonary rehabilitation program combined with inhaled procaterol can improve both HRQOL and exercise tolerance in COPD patients.